BRIEF published on 06/10/2026 at 07:35, 2 months 8 days ago Sensorion Advances SENS-601 for GJB2-Related Hearing Loss Clinical Trials Gene Therapy Sensorion SENS-601 GJB2 Hearing Loss
BRIEF published on 06/10/2026 at 07:35, 2 months 8 days ago Sensorion Refocuses on SENS-601 for Gene Therapy Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
PRESS RELEASE published on 06/10/2026 at 07:30, 2 months 8 days ago Inside Information / Other news releases Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 Clinical Trials Gene Therapy Sensorion Regulatory Milestones GJB2-related Hearing Loss
BRIEF published on 05/18/2026 at 07:35, 3 months ago Fred Chereau appointed Managing Director of Sensorion Gene Therapy General Management Hearing Loss Sensory Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 3 months ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 3 months ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 3 months 5 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
PRESS RELEASE published on 05/13/2026 at 07:30, 3 months 5 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
BRIEF published on 05/05/2026 at 07:35, 3 months 13 days ago Sensorion is participating in the ASGCT annual conference Gene Therapy Hearing Loss SENS-601 Sensory ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 3 months 13 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
Published on 08/19/2026 at 04:00, 48 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 5 hours 38 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 9 hours 3 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 10 hours 18 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 11 hours 8 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 22:00, 6 hours 48 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 6 hours 58 minutes ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 9 hours 48 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 10 hours 3 minutes ago Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 10 hours 38 minutes ago Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD
Published on 08/18/2026 at 11:15, 17 hours 33 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 9 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 1 day 20 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 1 day 21 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026
